For cell proliferation assay, ccRCC cells were seeded in 96‐well plates (1,500 cells/well) in fresh medium. At each time point, 10 μL of
Cell Counting Kit‐8 solution (
CCK‐8; Dojindo, Tokyo, Japan) was added directly to each well, followed by incubation for 3 h at 37°C. For drug treatment, cells were seeded in 96‐well plates (1,500 cells/well) with 100 μL culture medium, then treated with 2 μmol/L
gefitinib (MedChemExpress, Princeton, NJ, USA),
lenvatinib (MedChemExpress) or
cabozantinib (MedChemExpress) for 72 h, followed by adding
CCK‐8 solution. The optical density was measured at 450 nm (OD
450) by
Microplate Reader (BioTek, Vermont, USA). Each experiment was performed in triplicate.
In the colony formation assay, cells were plated in 6‐well plates (500 cells/well) in 2 mL of fresh medium and cultured for 10 days. Visible colonies were stained with 0.5% crystal violet, and colonies were counted with ImageJ software (National Institutes of Health, Bethesda, MD, USA).
Luo L., Wei D., Pan Y., Wang Q., Feng J., Yu B., Kang T., Luo J., Yang J, & Gao S. (2023). MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria‐dependent dephosphorylation of EGFR. Cancer Communications, 43(7), 808-833.